The biological seed treatment market is projected to reach USD 1.7 billion by 2025, from USD 0.9 billion in 2020, at a CAGR of 11.9% during the forecast period. The market has been growing at a significant rate due to the increasing need for a sustainable approach in agricultural operations in developed countries. Strong research funding by key manufacturers on product development such as compatible combinations of biological and chemical components is expected to drive the growth of the market over the next five years.

Bayer AG (Germany)

Syngenta Group (Switzerland) has been a leading player in the agricultural industry by offering diverse innovative solutions to the market place. Through its product investment & partnership approach, the company focuses on delivering sustainable solutions through its seed treatment technology in order to capitalize on a growing market demand for biological solutions, and progress to a formidable position at the preliminary stage of the market. It has a strong brand image and early mover advantage due to the introduction of Clariva, the first biological nematicide for seed treatment. In October 2020, Syngenta Group announced the acquisition of Valagro (Italy), a leading Biologicals company, through its business unit Syngenta Crop Protection. Through this strategy, Syngenta Crop Protection positions itself as one of the key global companies to shape the rapidly growing biologicals market, which is set to nearly double in size over the next five years.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

The post Biological Seed Treatment Market Size, Trends, and Key Players first appeared on MarketsandMarkets Blog.